Human Apolipoprotein A-II (Apo A2) ELISA Kit (High Sensitivity)

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

• https://www.archivesofmedicalscience.com/Is-it-time-to-change-the-goals-of-lipid-management-in-type-1-diabetes-mellitus-Changes,125529,0,2.html
• Cieluch A et al. (2020). Arch. Med. Sci. 18:1-8.
• No Snippet Provided

Impaired lipid transport in gestational diabetes mellitus

• http://www.hoajonline.com/journals/pdf/2050-0866-2-22.pdf
• Nichols SKF et al. (2013). Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22
• No Snippet Provided

Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients

• https://www.jstage.jst.go.jp/article/jat/20/9/20_17210/_pdf
• Miyamoto-Sasaki M et al. (2013). J Atheroscler Thromb. 20(9):708-16.
• No Snippet Provided

Investigating Changes in the Composition and the Function of High Density Lipoprotein after Roux-n-Y Bariatric Surgery

• https://www.research.manchester.ac.uk/portal/files/54550621/FULL_TEXT.PDF
• Hama S (2013). University of Manchester.
• No Snippet Provided

Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach

• http://www.mcponline.org/content/12/1/55.long
• Flood-Nichols SK et al. (2013). Molecular & Cellular Proteomics 12.1
• No Snippet Provided

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

• https://pubmed.ncbi.nlm.nih.gov/35591821/
• Aleksandra Cieluch, Aleksandra Uruska, ..., Dorota Zozulińska-Ziółkiewicz (2020). Archives of Medical Science. 2020 Oct 29
• ts: at the time of diagnosis (before administration of insulin) and at follow-up after 3 weeks, 6 months and 1 year of  insulin treatment. The  concentration of apo AI and apo AII was determined with AssayPro company tests using the immunoenzymatic method ELISA (enzyme-linked immunosorbent assay) using a  TECAN-SUNRISE reader Is it time to change the goals of lipid management in type 1 diabetes mel

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma

• https://pubmed.ncbi.nlm.nih.gov/24622469/
• Mika Hori, Mami Takahashi, ..., Hitoshi Nakagama (2014). Clinical and Translational Gastroenterolog…. 2014 Mar 13
• e National Cancer Center Biobank, Japan, was stored at −20°C. Serum adiponectin, leptin and insulin growth factor-I (IGF-I) (R & D Systems, Inc., Minneapolis, MN, USA), apolipoprotein A-II (apoA-II) (Assay pro, St Charles, MO, USA), insulin (Millipore, Billerica, MA, USA), and serum amyloid A (SAA; Invitrogen, Camarillo, CA, USA) were measured using enzyme-linked immunosorbent assay kits in accorda

Serum Protein Signatures Differentiating Autoimmune Pancreatitis versus Pancreatic Cancer

• https://pubmed.ncbi.nlm.nih.gov/24349355/
• Klaus Felix, Oliver Hauck, ..., Jens Werner (2013). PLoS ONE. 2013 Dec 09
• phase capture sandwich ELISAs were performed using commercially available kits for apolipoprotein A-I (ALerCHEK Inc., Portland, Maine). Apolipoprotein A-II, apolipoprotein E and haptoglobin were from AssayPro (AssayPro, St. Charles, MO), tetranectin from USCN Life Science Inc. (Wuhan, PRC), and transthyretin from Immundiagnostik AG (Bensheim, Germany). The haptoglobin ELISA from AssayPro is also a

Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach *

• https://pubmed.ncbi.nlm.nih.gov/23059768/
• Shannon K Flood-Nichols, Deborah Tinnemore, ..., Danielle L Ippolito (2013). Molecular & cellular proteomics : MCP. 2013 Jan 25
• po C-III, Apo A-I, and Apo A-II were used in ELISA assays to probe n = 5 patient specimens ( n = 2 technical replicates per patient) at 2–4 gestational ages according to manufacturer instructions (AssayPro, St. Charles, MO). Apolipoprotein concentration was determined by measuring optical densities at 450 nm absorption and interpolating to a standard calibration curve by microplate spectrophotom

Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients

• https://pubmed.ncbi.nlm.nih.gov/23739642/
• Maki Miyamoto-Sasaki, Tomoyuki Yasuda, ..., Ken-ichi Hirata (2013). Journal of atherosclerosis and thrombosis. 2013 Jan 01
• All values are presented as the mean±SD. Comparisons between the parameters of pre- and postpitavastatin treatment were made with paired Stu- measured using a commercially available ELISA kit (ASSAYPRO, MO, USA). The lipoprotein profiles were determined using HPLC (LipoSEARCH®) at Skylight Biotech, Inc. (Akita, Japan), according to the specified procedure21). The levels of HDL-phospholipids, total

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

• https://pubmed.ncbi.nlm.nih.gov/20588270/
• A Xue, C J Scarlett, ..., R C Smith (2010). British Journal of Cancer. 2010 Jul 27
• .. TX, USA) for which normal values were set at <37 U ml –1 .. Similarly, levels of ApoA-II and ApoC-I were measured by AssayMax ApoA-II ELISA kit and AssayMax ApoC-I ELISA kit (AssayPro, St Charles, MO, USA), respectively.. Absorbance was measured at 450 nm on a microplate reader (Tecan, Salzburg, Austria) within ..